If you look at past history, it hasn't been favourable to drugs lacking single-agent activity. Even if there is prolonged SD (with some minor shrinkage), that could be something, but I think it then should go on to be tested in a randomised and placebo-controlled trial.
News 
Market Data 
Discover 
